Sort
50,496 grants matching “lung cancer”
Early Life Conditions, Survival, and Health: A Pedigree-Based Population Study
$831,456Ken R Smith · University Of Utah · R01 · FY2014 · AG
[18F]ALPHAVBETA6-BINDING PEPTIDE POSITRON EMISSION TOMOGRAPHY FOR STAGING, RESPONSE ASSESSMENT, AND PATIENT SELECTION IN METASTATIC NON-SMALL CELL LUNG CANCER
$831,417University Of California, Davis · · FY2020 · Defense Health Agency
Interventions in Genetic Counseling
$831,290Barbara Bowles Biesecker · National Human Genome Research Institute · ZIA · FY2011 · HG
Explore a key nucleotide synthesis enzyme to develop a broad-spectrum antiviral therapy.
$831,235Pinghui Feng · University Of Southern California · R01 · FY2025 · AI
The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up
$831,076Julie E Buring · Brigham And Women'S Hospital · UM1 · FY2016 · CA
Cell and Chemical Biology of Microtubules
$830,954Timothy J Mitchison · Harvard Medical School · R35 · FY2023 · GM
Development of FISH Molecular Diagnostics to support Clinical Trials at NCI
$830,915Svetlana Pack · Division Of Basic Sciences - Nci · ZID · FY2011 · CA
Genetic Susceptibility To Carcinogens and Toxicants
$830,841Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Tumor gene expression in vitro and in vivo
$830,516Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Cell and Chemical Biology of Microtubules
$830,198Timothy J Mitchison · Harvard Medical School · R35 · FY2022 · GM
The NF-kappaB modulator PDLIM2 as an intrinsic checkpoint of alveolar macrophages critical for lung innate immunity, inflammation and diseases
$829,998Zhaoxia Qu · University Of Southern California · R01 · FY2025 · HL
LKB1 tumor suppressor and human cancer
$829,961Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2010 · CA
Pulmonary Diseases in WTC Workers: Symptoms, Function, and Chest CT Correlates
$829,943Rafael E. De La Hoz · Icahn School Of Medicine At Mount Sinai · U01 · FY2014 · OH
Pulmonary Diseases in WTC Workers: Symptoms, Function, and Chest CT Correlates
$829,943Rafael E. De La Hoz · Icahn School Of Medicine At Mount Sinai · U01 · FY2015 · OH
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
$829,937Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · MD
Biomarkers and mechanisms in cancer associated thrombosis
$829,929Robert C Flaumenhaft · Beth Israel Deaconess Medical Center · U01 · FY2022 · HL
Investigating the Roles of Patient Beliefs, Stigma, and Physician Implicit Bias on Disparities in Lung Cancer Screening
$829,767Minal S Kale · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MD
SINGAPORE COHORT STUDY OF DIET AND CANCER
$829,658University Of Southern California · R01 · FY2000 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2021 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2022 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2018 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2019 · CA
MUC1-C is a Target for Reversing Immune Evasion and Resistance to Immunotherapies
$829,650Donald W. Kufe · Dana-Farber Cancer Inst · U01 · FY2020 · CA
BIOSTATISTICS RESOURCE GROUP
$829,507Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P30 · FY2013 · CA
Molecular prediction of myeloma in African Americans
$829,309Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2024 · CA